Pilot Study of T-APCs Following CAR T Cell Immunotherapy for CD19+ Leukemia
Clinical trial NCT03186118 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03186118
- Sponsor
- Seattle Children's Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-04
- Primary completion
- 2021-09-13
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.